An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly improved recurrence risk stratification in hormone receptor (HR)-positive, ...
News-Medical.Net on MSN
AI model improves recurrence risk stratification in HR-positive, HER2-negative breast cancer
An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly ...
The AAN’s first-ever functional seizure guideline targets stigma and unnecessary treatment, offering clearer diagnostic steps ...
An official definition which recognises the 'unrelenting symptoms' faced by chronic UTI sufferers is expected in 2026 ...
This commentary on persistent idiopathic facial pain urges balanced dental and neurologic assessment, clearer differential ...
Organizations are relying on their IT departments more than ever as technology's influence widens across strategy, operations, and culture. However, many CIOs face misalignment between IT's actual ...
The Board of Directors of Zoetis Inc. has declared a dividend of $0.53 per share for the first quarter of 2026, an increase of 6% from the quarterly dividend rate paid in 2025. The dividend will be ...
FRIENDSWOOD, Texas, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health ...
Critical illness poses a significant global health challenge, disproportionately affecting low- and middle-income countries ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback